Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Alzheimer's Disease Neuroimaging Initiative 4 (ADNI4)

NCT05617014 is registered in ClinicalTrials.gov with University of Southern California as lead sponsor.

NCT NCT05617014
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05617014 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Alzheimer's Disease Neuroimaging Initiative 4 (ADNI4)
Lead sponsor
University of Southern California
Phase
Observational
Overall status
Enrolling by invitation
Start date
June 9, 2023
Completion date
July 31, 2027
Enrollment
1,500 (estimated)
Sites
65

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, dementia, mild cognitive impairment